Target
Phospholipase A2
Ligand
BDBM84017
Substrate
n/a
Meas. Tech.
Dose response counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay Set 2
IC50
11100±n/a nM
Citation
 PubChem, PC Dose response counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay Set 2 PubChem Bioassay (2011)[AID] 
Target
Name:
Phospholipase A2
Synonyms:
Group IB phospholipase A2 | PA21B_HUMAN | PLA2 | PLA2A | PLA2G1B | PPLA2 | Phosphatidylcholine 2-acylhydrolase 1B | Phospholipase A2 (PLA2) | Phospholipase A2 group 1B | phospholipase A2 precursor
Type:
Protein
Mol. Mass.:
16364.13
Organism:
Homo sapiens (Human)
Description:
P04054
Residue:
148
Sequence:
MKLLVLAVLLTVAAADSGISPRAVWQFRKMIKCVIPGSDPFLEYNNYGCYCGLGGSGTPVDELDKCCQTHDNCYDQAKKLDSCKFLLDNPYTHTYSYSCSGSAITCSSKNKECEAFICNCDRNAAICFSKAPYNKAHKNLDTKKYCQS
  
Inhibitor
Name:
BDBM84017
Synonyms:
MLS001126460 | SMR000629220 | [4-(3-chlorophenyl)-1-piperazinyl]-[1-(7,8,9,10-tetrahydro-6H-purino[9,8-a]azepin-4-yl)-4-piperidinyl]methanone | [4-(3-chlorophenyl)piperazin-1-yl]-[1-(7,8,9,10-tetrahydro-6H-purino[9,8-a]azepin-4-yl)piperidin-4-yl]methanone | [4-(3-chlorophenyl)piperazino]-[1-(7,8,9,10-tetrahydro-6H-purin[9,8-a]azepin-4-yl)-4-piperidyl]methanone | cid_16021603
Type:
Small organic molecule
Emp. Form.:
C26H32ClN7O
Mol. Mass.:
494.032
SMILES:
Clc1cccc(c1)N1CCN(CC1)C(=O)C1CCN(CC1)c1ncnc2n3CCCCCc3nc12
Structure:
Search PDB for entries with ligand similarity: